BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 16337389)

  • 1. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
    Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
    Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M;
    Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
    Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
    Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
    Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
    Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
    Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
    Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
    Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS
    Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
    Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
    Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
    Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
    Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
    Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
    Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
    Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
    Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
    South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.